Web-based analysis on the role of Digital Media in Health Communication: the experience of VaccinarSinSardegna Website.
Journal
Acta bio-medica : Atenei Parmensis
ISSN: 2531-6745
Titre abrégé: Acta Biomed
Pays: Italy
ID NLM: 101295064
Informations de publication
Date de publication:
01 10 2021
01 10 2021
Historique:
received:
27
07
2021
accepted:
01
09
2021
entrez:
5
11
2021
pubmed:
6
11
2021
medline:
12
11
2021
Statut:
epublish
Résumé
Vaccinarsinsardegna.org website is a medical and scientific communication portal regarding vaccinations of Sardinia region. This article aims to present the structure of the portal, to demonstrate the actions carried out to provide accurate information for users and to analyse the website's activity from its launch until the current pandemic period in terms of dissemination and visibility. Various metrics such as the number of visits to the site (sessions, number of users and average session duration), user behaviour (pages viewed, bounce rate and organic search) and the session acquisition path (direct traffic, referrals and social traffic) were recorded, extrapolated and processed with Google Analytics. Qualitative and normally distributed quantitative variables were summarised with absolute (relative) frequencies and means. The statistical differences between the two periods (before and during the anti-COVID-19 vaccination campaign) were evaluated applying the Wilkoxon runk-sum test. A two-tailed p-value less than 0.01 was considered to be statistically significant. The metrics recorded using Google Analytics show that from its publication to date, the VaccinarSinSardegna.org portal has significantly increased its visibility: in fact, the number of users who have accessed the site, the number of sessions and individual web pages visited have grown exponentially. These findings are confirmed by the increasing number of visits to both versions of the regional website (Italian- and English-language) during the COVID-19 emergency and COVID-19 vaccination campaign. When the total values recorded over the period were compared, an overall increase in metrics was observed-the number of individual users, visits and individual pageviews rose in a statistically significant way. Based on the success on VaccinarSinSardegna and given its potential for expansion to include further collaborations with national and international scientific bodies, the authors affirm that similar initiatives should be implemented in the fight against vaccine hesistancy.
Sections du résumé
BACKGROUND AND AIM
Vaccinarsinsardegna.org website is a medical and scientific communication portal regarding vaccinations of Sardinia region. This article aims to present the structure of the portal, to demonstrate the actions carried out to provide accurate information for users and to analyse the website's activity from its launch until the current pandemic period in terms of dissemination and visibility.
METHODS
Various metrics such as the number of visits to the site (sessions, number of users and average session duration), user behaviour (pages viewed, bounce rate and organic search) and the session acquisition path (direct traffic, referrals and social traffic) were recorded, extrapolated and processed with Google Analytics. Qualitative and normally distributed quantitative variables were summarised with absolute (relative) frequencies and means. The statistical differences between the two periods (before and during the anti-COVID-19 vaccination campaign) were evaluated applying the Wilkoxon runk-sum test. A two-tailed p-value less than 0.01 was considered to be statistically significant.
RESULTS
The metrics recorded using Google Analytics show that from its publication to date, the VaccinarSinSardegna.org portal has significantly increased its visibility: in fact, the number of users who have accessed the site, the number of sessions and individual web pages visited have grown exponentially. These findings are confirmed by the increasing number of visits to both versions of the regional website (Italian- and English-language) during the COVID-19 emergency and COVID-19 vaccination campaign. When the total values recorded over the period were compared, an overall increase in metrics was observed-the number of individual users, visits and individual pageviews rose in a statistically significant way.
CONCLUSIONS
Based on the success on VaccinarSinSardegna and given its potential for expansion to include further collaborations with national and international scientific bodies, the authors affirm that similar initiatives should be implemented in the fight against vaccine hesistancy.
Identifiants
pubmed: 34739476
doi: 10.23750/abm.v92iS6.12072
pmc: PMC8851010
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2021456Références
Int J Environ Res Public Health. 2020 May 03;17(9):
pubmed: 32375260
JMIR Mhealth Uhealth. 2020 Feb 21;8(2):e12229
pubmed: 32130153
Hum Vaccin Immunother. 2013 Aug;9(8):1802-11
pubmed: 23807361
Front Public Health. 2021 Mar 18;9:610623
pubmed: 33816415
Vaccine. 2018 Aug 28;36(36):5424-5429
pubmed: 28610824
Public Health. 2021 Sep;198:44-52
pubmed: 34352615
Hum Vaccin Immunother. 2017 Feb;13(2):339-345
pubmed: 28032814
Vaccines (Basel). 2021 Aug 30;9(9):
pubmed: 34579208
J Prev Med Hyg. 2019 Feb 28;59(4 Suppl 2):E45-E50
pubmed: 31016267
Ann Ig. 2021 Mar-Apr;33(2):109-122
pubmed: 33570083
Acta Biomed. 2020 Jul 20;91(9-S):61-75
pubmed: 32701918
J Med Internet Res. 2014 Jan 17;16(1):e20
pubmed: 24440770
Front Public Health. 2016 Mar 08;4:36
pubmed: 27014673
Lancet Infect Dis. 2021 Feb;21(2):160-161
pubmed: 32888411
Int J Environ Res Public Health. 2021 Mar 23;18(6):
pubmed: 33806848
Sci Total Environ. 2019 Nov 15;691:1162-1172
pubmed: 31466198
Hum Vaccin Immunother. 2020 Oct 2;16(10):2415-2421
pubmed: 32186961
J Med Internet Res. 2016 Jan 28;18(1):e18
pubmed: 26822073
Ann Ig. 2014 May-Jun;26(3 Suppl 1):54-64
pubmed: 25486693
Hum Vaccin Immunother. 2019;15(11):2508-2526
pubmed: 30932725
Ann Med. 2018 Mar;50(2):110-120
pubmed: 29172780
Eur J Public Health. 2019 Oct 1;29(Supplement_3):28-35
pubmed: 31738441
J Infect Dev Ctries. 2010 Jun 03;4(5):264-6
pubmed: 20539058
Vaccine. 2010 Feb 17;28(7):1709-16
pubmed: 20045099
Vaccines (Basel). 2020 May 30;8(2):
pubmed: 32486233
EMBO Mol Med. 2014 May 06;6(6):708-20
pubmed: 24803000
BMC Public Health. 2019 Nov 15;19(1):1532
pubmed: 31730455
Vaccine. 2021 Feb 22;39(8):1187-1189
pubmed: 33309482
BMC Res Notes. 2010 Oct 06;3:250
pubmed: 20925916
Vaccines (Basel). 2020 Nov 03;8(4):
pubmed: 33153005
Int J Environ Res Public Health. 2018 Jul 18;15(7):
pubmed: 30021934
Int J Environ Res Public Health. 2021 May 25;18(11):
pubmed: 34070427
Epidemiol Prev. 2015 Jul-Aug;39(4 Suppl 1):88-93
pubmed: 26499422
Pediatr Ann. 2015 Apr;44(4):e71-5
pubmed: 25875982
Environ Res. 2021 Jan;192:110459
pubmed: 33188767
Hu Li Za Zhi. 2020 Oct;67(5):6-11
pubmed: 32978760
Clin Ther. 2017 Aug;39(8):1550-1562
pubmed: 28774498
Expert Rev Vaccines. 2015 Jan;14(1):99-117
pubmed: 25373435
Int J Environ Res Public Health. 2020 Jul 06;17(13):
pubmed: 32640725
J Med Internet Res. 2020 May 4;22(5):e18825
pubmed: 32314976
JMIR Mhealth Uhealth. 2020 May 25;8(5):e14375
pubmed: 32449688